Our goal is to realize a new drug discovery ecosystem that transcends the boundaries of traditional hierarchical organizational structures. We will realize a self-organized drug discovery promotion system led by a small team with a common goal of creating new drugs, and by mutually cooperating with diverse internal and external stakeholders and flexibly sharing tasks.

Tensegrity Pharma was founded by a CEO with extensive experience in promoting new drug programs in both pharma and venture, The Executive Advisory Board (coming soon) comprised of individuals with experience in R&D, business development, CMC, and MA in pharma, academia and venture. We will formulate high-quality early-stage clinical development plans and promote clinical development programs leveraging our extensive network of domestic and international investigators, CROs, and global KOLs.

Founder, President & CEO,  Takahito Nakahara, Ph.D.
​
March 2023 Founder, President&CEO, Tensegrity Pharma, Inc. (Present)
2020-2023   Senior Vice President, Modulus Discovery Inc. (Translational Science, Business Development)
2016-2020 Executive Director, Head of Research Program Management Office, Astellas Pharma, Inc.
2012-2016  Corporate Planning Director,  Astellas Pharma, Inc. 
2007-2012 Senior Director, Astellas Pharma Global Development Inc. (Global Deevlopment Project Leader in Oncology, based in U.S.)
1993-2007 Research Scientist, Yamanouchi Pharmaceutical (=Astellas Pharma, Inc.)
1988-1993 Shizuoka University (MSc), 2011 Tokyo University of Science, Pharmaceutical Sciences (Ph.D.)